Integrating the puzzle pieces: The current atomistic picture of phospholipid-G protein coupled receptor interactions

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 1, 2013, Pages 2-12

  Parrill, Abby L ^a   Tigyi, Gabor ^b  

^a University of Memphis   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

GPCR structure; LPA; S1P; Structure activity relationships

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DISULFIDE BOND; ENTHALPY; HYDROGEN BOND; HYDROPHOBICITY; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHOLIPIDS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84868556353     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.09.002     Document Type: Review

References (84)

1. V. Brinkmann, M.D. Davis, C.E. Heise, R. Albert, S. Cottens, R. Hof, C. Bruns, E. Prieschl, T. Baumruker, P. Hiestand, C.A. Foster, M. Zollinger, and K.R. Lynch The immune modulator, FTY720, targets sphingosine 1-phosphate receptors J. Biol. Chem. 277 2002 21453 21457
2. S. Mandala, R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G. Shei, D. Card, C. Keohane, M. Rosenbach, J. Hale, C.L. Lynch, K. Rupprecht, W. Parsons, and H. Rosen Alteration of lymphocyte trafficking by sphingosine 1-phosphate receptor agonists Science 296 2002 346 349
3. K.L. Napoli The FTY720 story Ther. Drug Monit. 22 2000 47 51
4. M.H. Graler, and E.J. Goetzl The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors FASEB J. 18 2004 551 553
5. M. Matloubian, C.G. Lo, G. Cinamon, M.J. Lesneski, Y. Xu, V. Brinkmann, M.L. Allende, R.L. Proia, and J.G. Cyster Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 Nature 427 2004 355 360
6. D.J. Buzard, J. Thatte, M. Lerner, J. Edwards, and R.M. Jones Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders Expert Opin. Ther. Patents 18 2008 1141 1159
7. J.J. Hale, W. Neway, S.G. Mills, R. Hajdu, C. Ann Keohane, M. Rosenbach, J. Milligan, G.J. Shei, G. Chrebet, J. Bergstrom, D. Card, G.C. Koo, S.L. Koprak, J.J. Jackson, H. Rosen, and S. Mandala Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720 Bioorg. Med. Chem. Lett. 14 2004 3351 3355
8. J.J. Hale, G. Doherty, L. Toth, Z. Li, S.G. Mills, R. Hajdu, C. Ann Keohane, M. Rosenbach, J. Milligan, G.J. Shei, G. Chrebet, J. Bergstrom, D. Card, H. Rosen, and S. Mandala The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonists Bioorg. Med. Chem. Lett. 14 2004 3495 3499
9. J.J. Clemens, M.D. Davis, K.R. Lynch, and T.L. Macdonald Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists Bioorg. Med. Chem. Lett. 15 2005 3568 3572
10. F.W. Foss Jr., J.J. Clemens, M.D. Davis, A.H. Snyder, M.A. Zigler, K.R. Lynch, and T.L. Macdonald Synthesis, stability, and implications of phosphothioate agonists of sphingosine-1-phosphate receptors Bioorg. Med. Chem. Lett. 15 2005 4470 4474
11. D. Buzard, S.D. Han, L. Thoresen, J. Moody, L. Lopez, A. Kawasaki, T. Schrader, C. Sage, Y.H. Gao, J. Edwards, J. Barden, J. Thatte, L.X. Fu, M. Solomon, L. Liu, H. Al-Shamma, J. Gatlin, M. Le, C. Xing, S. Espinola, and R.M. Jones Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P1 agonists Bioorg. Med. Chem. Lett. 21 2011 6013 6018
12. V.J. Cee, M. Frohn, B.A. Lanman, J. Golden, K. Muller, S. Neira, A. Pickrell, H. Arnett, J. Buys, A. Gore, M. Fiorino, M. Horner, A. Itano, M.R. Lee, M. McElvain, S. Middleton, M. Schrag, D. Rivenzon-Segal, H.M. Vargas, H. Xu, Y. Xu, X.X. Zhang, J. Siu, M. Wong, and R.W. Burli Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P(1) and S1P(5) Acs Med. Chem. Lett. 2 2011 107 112
13. E.H. Demont, B.I. Andrews, R.A. Bit, C.A. Campbell, J.W.B. Cooke, N. Deeks, S. Desai, S.J. Dowell, P. Gaskin, J.R.J. Gray, A. Haynes, D.S. Holmes, U. Kumar, M.A. Morse, G.J. Osborne, T. Panchal, B. Patel, A. Perboni, S. Taylor, R. Watson, J. Witherington, and R. Willis Discovery of a selective S1P(1) receptor agonist efficacious at low oral dose and devoid of effects on heart rate Acs Med. Chem. Lett. 2 2011 444 449
14. H. Kurata, K. Kusumi, K. Otsuki, R. Suzuki, M. Kurono, N. Tokuda, Y. Takada, H. Shioya, H. Mizuno, T. Komiya, T. Ono, H. Hagiya, M. Minami, S. Nakade, and H. Habashita Structure-activity relationship studies of S1P agonists with a dihydronaphthalene scaffold Bioorg. Med. Chem. Lett. 22 2012 144 148
15. T. Nakamura, M. Asano, Y. Sekiguchi, Y. Mizuno, K. Tamaki, T. Kimura, F. Nara, Y. Kawase, T. Shimozato, H. Doi, T. Kagari, W. Tomisato, R. Inoue, M. Nagasaki, H. Yuita, K. Oguchi-Oshima, R. Kaneko, N. Watanabe, Y. Abe, and T. Nishi Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist Bioorg. Med. Chem. Lett. 22 2012 1788 1792
16. A.K. Saha, X.A. Yu, J.A. Lin, M. Lobera, A. Sharadendu, S. Chereku, N. Schutz, D. Segal, Y. Marantz, D. McCauley, S. Middleton, J. Siu, R.W. Burli, J. Buys, M. Horner, K. Salyeris, M. Schrag, H.M. Vargas, Y. Xu, M. McElvain, and H. Xu Benzofuran derivatives as potent, orally active S1P(1) receptor agonists: a preclinical lead molecule for MS Acs Med. Chem. Lett. 2 2011 97 101
17. J.J. Hale, C.L. Lynch, W. Neway, S.G. Mills, R. Hajdu, C.A. Keohane, M.J. Rosenbach, J.A. Milligan, G.J. Shei, S.A. Parent, G. Chrebet, J. Bergstrom, D. Card, M. Ferrer, P. Hodder, B. Strulovici, H. Rosen, and S. Mandala A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists J. Med. Chem. 47 2004 6662 6665
18. Z. Li, W. Chen, J.J. Hale, C.L. Lynch, S.G. Mills, R. Hajdu, C.A. Keohane, M.J. Rosenbach, J.A. Milligan, G.J. Shei, G. Chrebet, S.A. Parent, J. Bergstrom, D. Card, M. Forrest, E.J. Quackenbush, L.A. Wickham, H. Vargas, R.M. Evans, H. Rosen, and S. Mandala Discovery of potent 3,5-diphenyl-1,2,4- oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3 J. Med. Chem. 48 2005 6169 6173
19. 1-selective in vivo-active agonists from high throughput screening: off-the-shelf chemical probes of receptor interactions, signaling and fate Chem. Biol. 12 2005 703 715
20. M.G. Sanna, J. Liao, E. Jo, C. Alfonso, M.Y. Ahn, M.S. Peterson, B. Webb, S. Lefebvre, J. Chun, N. Gray, and H. Rosen Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate J. Biol. Chem. 279 2004 13839 13848
21. M.H. Bolli, S. Abele, C. Binkert, R. Bravo, S. Buchmann, D. Bur, J. Gatfield, P. Hess, C. Kohl, C. Mangold, B. Mathys, K. Menyhart, C. Muller, O. Nayler, M. Scherz, G. Schmidt, V. Sippel, B. Steiner, D. Strasser, A. Treiber, and T. Weller 2-Imino-thiazolidin-4-one derivatives as potent, orally active S1P(1) receptor agonists J. Med. Chem. 53 2010 4198 4211
22. E.H. Demont, S. Arpino, R.A. Bit, C.A. Campbell, N. Deeks, S. Desai, S.J. Dowell, P. Gaskin, J.R. Gray, L.A. Harrison, A. Haynes, T.D. Heightman, D.S. Holmes, P.G. Humphreys, U. Kumar, M.A. Morse, G.J. Osborne, T. Panchal, K.L. Philpott, S. Taylor, R. Watson, R. Willis, and J. Witherington Discovery of a brain-penetrant S1P(3)-sparing direct agonist of the S1P(1) and S1P(5) receptors efficacious at low oral dose J. Med. Chem. 54 2011 6724 6733
23. P.E. Harrington, M.D. Croghan, C. Fotsch, M. Frohn, B.A. Lanman, L.D. Pennington, A.J. Pickrell, A.B. Reed, K.K.C. Sham, A. Tasker, H.A. Arnett, M. Fiorino, M.R. Lee, M. McElvain, H.G. Morrison, H. Xu, Y. Xu, X.X. Zhang, M. Wong, and V.J. Cee Optimization of a potent, orally active S1P(1) agonist containing a quinolinone core Acs Med. Chem. Lett. 3 2012 74 78
24. X.H. He, L.L. Wang, Z.B. Zheng, J.H. Xiao, W. Zhong, and S. Li Novel immunomodulators based on an oxazolin-2-one-4-carboxamide scaffold Bioorg. Med. Chem. Lett. 22 2012 553 557
25. L.D. Pennington, K.K.C. Sham, A.J. Pickrell, P.E. Harrington, M.J. Frohn, B.A. Lanman, A.B. Reed, M.D. Croghan, M.R. Lee, H. Xu, M. McElvain, Y. Xu, X.X. Zhang, M. Fiorino, M. Horner, H.G. Morrison, H.A. Arnett, C. Fotsch, M. Wong, and V.J. Cee 4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl] nicotinamide: a potent and selective agonist of S1P(1) Acs Med. Chem. Lett. 2 2011 752 757
26. A.L. Parrill, D.-A. Wang, D.L. Bautista, J.R. Van Brocklyn, Z. Lorincz, D.J. Fischer, D.L. Baker, K. Liliom, S. Spiegel, and G. Tigyi Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate J. Biol. Chem. 275 2000 39379 39384
27. 4 within the endothelial differentiation gene family of receptors Biochem. J. 389 2005 187 195
28. W.J. Valentine, G.N. Kiss, J. Liu, E. S., M. Gotoh, K. Murakami-Murofushi, T.C. Pham, D.L. Baker, A.L. Parrill, X. Lu, C. Sun, R. Bittman, N.J. Pyne, and G. Tigyi (S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity Cell. Signal. 22 2010 1543 1553
29. L. Yan, J.J. Hale, C.L. Lynch, R. Budhu, A. Gentry, S.G. Mills, R. Hajdu, C.A. Keohane, M.J. Rosenbach, J.A. Milligan, G. Shei, G. Chrebet, J.D. Bergstrom, D. Card, H. Rosen, and S.M. Mandala Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors Bioorg. Med. Chem. Lett. 14 2004 4861 4866
30. F.W. Foss Jr., A.H. Snyder, M.D. Davis, M. Rouse, M.D. Okusa, K.R. Lynch, and T.L. Macdonald Synthesis and biological evaluation of gamma- aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists Bioorg. Med. Chem. 15 2007 663 677
31. M.D. Davis, J.J. Clemens, T.L. Macdonald, and K.R. Lynch Sphingosine 1-phosphate analogs as receptor antagonists J. Biol. Chem. 280 2005 9833 9841
32. J.J. Clemens, M.D. Davis, K.R. Lynch, and T.L. Macdonald Synthesis of para-alkyl aryl amide analogues of sphingosine-1-phosphate: discovery of potent S1P receptor agonists Bioorg. Med. Chem. Lett. 13 2003 3401 3404
33. D.-S. Im, J. Clemens, T.L. Macdonald, and K.R. Lynch Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): structure-activity relationship of sphingosine 1-phosphate receptors Biochemistry 40 2001 14053 14060
34. J.J. Clemens, M.D. Davis, K.R. Lynch, and T.L. Macdonald Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists Bioorg. Med. Chem. Lett. 14 2004 4903 4906
35. F.W. Foss Jr., T.P. Mathews, Y. Kharel, P.C. Kennedy, A.H. Snyder, M.D. Davis, K.R. Lynch, and T.L. Macdonald Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs Bioorg. Med. Chem. 17 2009 6123 6136
36. J.J. Hale, G. Doherty, L. Toth, S.G. Mills, R. Hajdu, C.A. Keohane, M. Rosenbach, J. Milligan, G.J. Shei, G. Chrebet, J. Bergstrom, D. Card, M. Forrest, S.Y. Sun, S. West, H. Xie, N. Nomura, H. Rosen, and S. Mandala Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists Bioorg. Med. Chem. Lett. 14 2004 3501 3505
37. 1 (EDG2) phospholipid growth factor receptors J. Biol. Chem. 276 2001 49213 49220
38. G. Holdsworth, D.A. Osborne, T.T. Pham, J.I. Fells, G. Hutchinson, G. Milligan, and A.L. Parrill A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor BMC Biochem. 5 2004 12
39. S.C. Schurer, S.J. Brown, P.J. Gonzalez-Cabrera, M.T. Schaeffer, J. Chapman, E. Jo, P. Chase, T. Spicer, P. Hodder, and H. Rosen Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P(1) and S1P(3) determine efficiency of chemical probe identification by ultrahigh-throughput screening ACS Chem. Biol. 3 2008 486 498
40. T.C. Pham, J.I. Fells Sr., D.A. Osborne, E.J. North, M.M. Naor, and A.L. Parrill Molecular recognition in the sphingosine 1-phosphate receptor family J. Mol. Graph. Model. 26 2008 1189 1201
41. M. Frohn, V.J. Cee, B.A. Lanman, A.J. Pickrell, J. Golden, D. Rivenzon-Segal, S. Middleton, M. Fiorino, H. Xu, M. Schrag, Y. Xu, M. McElvain, K. Muller, J. Siu, and R. Burli Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: potent S1P(1) agonists with in vivo lymphocyte-depleting activity Bioorg. Med. Chem. Lett. 22 2012 628 633
42. H. Kurata, K. Otsuki, K. Kusumi, M. Kurono, M. Terakado, T. Seko, H. Mizuno, T. Ono, H. Hagiya, M. Minami, S. Nakade, and H. Habashita Structure-activity relationship studies of sphingosine-1-phosphate receptor agonists with N-cinnamyl-beta-alanine moiety Bioorg. Med. Chem. Lett. 21 2011 1390 1393
43. W.J. Valentine, V.I. Godwin, D.A. Osborne, J. Liu, Y. Fujiwara, J. Van Brocklyn, R. Bittman, A.L. Parrill, and G. Tigyi FTY720 (Gilenya) phosphate selectivity of sphingosine 1-phosphate receptor subtype 1 (S1P1) G protein-coupled receptor requires motifs in intracellular loop 1 and transmembrane domain 2 J. Biol. Chem. 286 2011 30513 30525
44. G. Tigyi, and A.L. Parrill Molecular mechanisms of lysophosphatidic acid action Prog. Lipid Res. 42 2003 498 526
45. A.L. Parrill, V.M. Sardar, and H. Yuan Sphingosine 1-phosphate and lysophosphatidic acid receptors: agonist and antagonist binding and progress toward development of receptor-specific ligands Semin. Cell Dev. Biol. 15 2004 467 476
46. Y. Xu, J. Aoki, K. Shimizu, M. Umezu-Goto, K. Hama, Y. Takanezawa, S.X. Yu, G.B. Mills, H. Arai, L. Qian, and G.D. Prestwich Structure-activity relationships of fluorinated lysophosphatidic acid analogues J. Med. Chem. 48 2005 3319 3327
47. G. Jiang, Y. Xu, Y. Fujiwara, T. Tsukahara, R. Tsukahara, J. Gajewiak, G. Tigyi, and G.D. Prestwich Alpha-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA ChemMedChem 2 2007 679 690
48. Y. Xu, G.W. Jiang, R. Tsukahara, Y. Fujiwara, G. Tigyi, and G.D. Prestwich Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: novel antagonists of lysophosphatidic acid receptors J. Med. Chem. 49 2006 5309 5315
49. J.R. Williams, A.L. Khandoga, P. Goyal, J.I. Fells, D.H. Perygin, W. Siess, A.L. Parrill, G. Tigyi, and Y. Fujiwara Unique ligand selectivity of the GPR92/LPA(5) lysophosphatidate receptor indicates role in human platelet activation J. Biol. Chem. 284 2009 17304 17319
50. J. Gajewiak, R. Tsukahara, T. Tsukahara, Y. Fujiwara, S. Yu, W. Lu, M. Murph, G.B. Mills, G. Tigyi, and G.D. Prestwich Alkoxymethylenephosphonate analogues of (lyso)phosphatidic acid stimulate signaling networks coupled to the LPA(2) receptor ChemMedChem 2 2007 1789 1798
51. J. Gajewiak, and G.D. Prestwich Phosphomimetic sulfonamide and sulfonamidoxy analogues of (lyso)phosphatidic acid Tetrahedron Lett. 47 2006 7607 7609
52. G.G. Durgam, T. Virag, M.D. Walker, R. Tsukahara, S. Yasuda, K. Liliom, L.A. van Meeteren, W.H. Moolenaar, N. Wilke, W. Siess, G. Tigyi, and D.D. Miller Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin J. Med. Chem. 48 2005 4919 4930
53. T. Virag, D.B. Elrod, K. Liliom, V.M. Sardar, A.L. Parrill, K. Yokoyama, G. Durgam, W. Deng, D.D. Miller, and G. Tigyi Fatty alcohol phosphates are subtype-selective agonists and antagonists of LPA receptors Mol. Pharmacol. 63 2003 1032 1042
54. A.L. Khandoga, Y. Fujiwara, P. Goyal, D. Pandey, R. Tsukahara, A. Bolen, H. Guo, N. Wilke, J. Liu, W.J. Valentine, G.G. Durgam, D.D. Miller, G. Jiang, G.D. Prestwich, G. Tigyi, and W. Siess Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin Platelets 19 2008 415 427
55. K. Yanagida, K. Masago, H. Nakanishi, Y. Kihara, F. Hamano, Y. Tajima, R. Taguchi, T. Shimizu, and S. Ishii Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6 J. Biol. Chem. 284 2009 17731 17741
56. K. Bandoh, J. Aoki, A. Taira, M. Tsujimoto, H. Arai, and K. Inoue Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species: structure-activity relationship of cloned LPA receptors FEBS Lett. 478 2000 159 165
57. G.G. Durgam, R. Tsukahara, N. Makarova, M.D. Walker, Y. Fujiwara, K.R. Pigg, D.L. Baker, V.M. Sardar, A.L. Parrill, G. Tigyi, and D.D. Miller Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands Bioorg. Med. Chem. Lett. 16 2006 633 640
58. Y. Fujiwara, V. Sardar, A. Tokumura, D. Baker, K. Murakami-Murofushi, A. Parrill, and G. Tigyi Identification of residues responsible for ligand recognition and regioisomeric selectivity of lysophosphatidic acid receptors expressed in mammalian cells J. Biol. Chem. 280 2005 35038 35050
59. W.J. Valentine, J.I. Fells, D.H. Perygin, S. Mujahid, K. Yokoyama, Y. Fujiwara, R. Tsukahara, J.R. Van Brocklyn, A.L. Parrill, and G. Tigyi Subtype-specific residues involved in ligand activation of the endothelial differentiation gene family lysophosphatidic acid receptors J. Biol. Chem. 283 2008 12175 12187
60. M.A. Hanson, C.B. Roth, E. Jo, M.T. Griffith, F.L. Scott, G. Reinhart, H. Desale, B. Clemons, S.M. Cahalan, S.C. Schuerer, M.G. Sanna, G.W. Han, P. Kuhn, H. Rosen, and R.C. Stevens Crystal structure of a lipid G protein-coupled receptor Science 335 2012 851 855
61. V. Cherezov, D.M. Rosenbaum, M.A. Hanson, S.G. Rasmussen, F.S. Thian, T.S. Kobilka, H.J. Choi, P. Kuhn, W.I. Weis, B.K. Kobilka, and R.C. Stevens High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor Science 318 2007 1258 1265
62. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, and P.E. Bourne The Protein Data Bank Nucleic Acids Res. 28 2000 235 242
63. A.L. Parrill, D.L. Baker, D. Wang, D.J. Fischer, D.L. Bautista, J. van Brocklyn, S. Spiegel, and G. Tigyi Structural features of EDG1 receptor-ligand complexes revealed by computational modeling and mutagenesis E.J. Goetzl, K.R. Lynch, Lysophospholipids and Eicosanoids in Biology and Pathophysiology vol. 905 2000 New York Academy of Sciences New York 330 339
64. H. Lim, J. Park, K. Ko, M. Lee, and S. Chung Syntheses of sphingosine-1-phosphate analogues and their interaction with EDG/S1P receptors Bioorg. Med. Chem. Lett. 14 2004 2499 2503
65. P.B. van Loenen, C. de Graaf, D. Verzijl, R. Leurs, D. Rognan, S.L. Peters, and A.E. Alewijnse Agonist-dependent effects of mutations in the sphingosine-1-phosphate type 1 receptor Eur. J. Pharmacol. 667 2011 105 112
66. Q.L. Deng, J.A. Clemas, G. Chrebet, P. Fischer, J.J. Hale, Z. Li, S.G. Mills, J. Bergstrom, S. Mandala, R. Mosley, and S.A. Parent Identification of Leu276 of the S1P(1) receptor and Phe263 of the S1P(3) receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies Mol. Pharmacol. 71 2007 724 735
67. Y. Fujiwara, D.A. Osborne, M.D. Walker, D.A. Wang, D.A. Bautista, K. Liliom, J.R. Van Brocklyn, A.L. Parrill, and G. Tigyi Identification of the hydrophobic ligand binding pocket of the S1P1 receptor J. Biol. Chem. 282 2007 2374 2385
68. A.L. Parrill, S. Lima, and S. Spiegel Structure of the first sphingosine 1-phosphate receptor Sci. Signal. 5 2012 e23
69. T.T. Pham, R.W. Kriwacki, and A.L. Parrill Peptide design and structural characterization of a GPCR loop mimetic Biopolymers 86 2007 298 310
70. T. Yamada, Y. Ohoka, M. Kogo, and S. Inagaki Physical and functional interactions of the lysophosphatidic acid receptors with PDZ domain-containing Rho guanine nucleotide exchange factors (RhoGEFs) J. Biol. Chem. 280 2005 19358 19363
71. H. Zhang, D. Wang, H. Sun, R.A. Hall, and C.C. Yun MAGI-3 regulates LPA-induced activation of Erk and RhoA Cell. Signal. 19 2007 261 268
72. A.K. Singh, B. Riederer, A. Krabbenhoft, B. Rausch, J. Bonhagen, U. Lehmann, H.R. de Jonge, M. Donowitz, C. Yun, E.J. Weinman, O. Kocher, B.M. Hogema, and U. Seidler Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice J. Clin. Invest. 119 2009 540 550
73. S.J. Lee, S.L. Ritter, H. Zhang, H. Shim, R.A. Hall, and C.C. Yun MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells Gastroenterology 140 2011 924 934
74. S. Lin, S. Yeruva, P. He, A.K. Singh, H. Zhang, M. Chen, G. Lamprecht, H.R. de Jonge, M. Tse, M. Donowitz, B.M. Hogema, J. Chun, U. Seidler, and C.C. Yun Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2 Gastroenterology 138 2010 649 658
75. F.T. Lin, Y.J. Lai, N. Makarova, G. Tigyi, and W.C. Lin The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival J. Biol. Chem. 282 2007 37759 37769
76. F. Chu, J. Barkinge, S. Hawkins, R. Gudi, R. Salgia, and P.V. Kanteti Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2 Cancer Res. 65 2005 5301 5309
77. L. Xue, F. Chu, Y. Cheng, X. Sun, A. Borthakur, M. Ramarao, P. Pandey, M. Wu, S.F. Schlossman, and K.V. Prasad Siva-1 binds to and inhibits BCL-X(L)-mediated protection against UV radiation-induced apoptosis Proc. Natl. Acad. Sci. U. S. A. 99 2002 6925 6930
78. E. Shuyu, Y.J. Lai, R. Tsukahara, C.S. Chen, Y. Fujiwara, J. Yue, J.H. Yu, H. Guo, A. Kihara, G. Tigyi, and F.T. Lin Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect J. Biol. Chem. 284 2009 14558 14571
79. J.L. Kadrmas, and M.C. Beckerle The LIM domain: from the cytoskeleton to the nucleus Nat. Rev. Mol. Cell Biol. 5 2004 920 931
80. M. Hervy, L. Hoffman, and M.C. Beckerle From the membrane to the nucleus and back again: bifunctional focal adhesion proteins Curr. Opin. Cell Biol. 18 2006 524 532
81. V.T. Lin, and F.T. Lin TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity Cell. Signal. 23 2011 1691 1697
82. Y.J. Lai, V.T. Lin, Y. Zheng, E.N. Benveniste, and F.T. Lin The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration Mol. Cell. Biol. 30 2010 5582 5596
83. B.A. Ledezma-Sanchez, A. Garcia-Regalado, M.L. Guzman-Hernandez, and J. Vazquez-Prado Sphingosine-1-phosphate receptor S1P1 is regulated by direct interactions with P-Rex1, a Rac guanine nucleotide exchange factor Biochem. Biophys. Res. Commun. 391 2010 1647 1652
84. M.D. Medlin, D.P. Staus, A.D. Dubash, J.M. Taylor, and C.P. Mack Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation Arterioscler. Thromb. Vasc. Biol. 30 2010 1779 1786